| Document |
Document Title |
|
WO/2023/145804A1 |
The purpose of the present invention is to provide a novel B0AT1 inhibitor. The present invention relates to a compound represented by formula (I): (the symbols in the formula are as described in the description) or a salt thereof. The p...
|
|
WO/2023/145758A1 |
Provided is a method for producing a fluorine-containing phthalic acid derivative, whereby a fluorine-containing phthalic acid derivative can be obtained using a simple process. This method for producing a fluorine-containing phthalic ac...
|
|
WO/2023/142618A1 |
Provided is a synthesis method for Euphorbia diterpenoid Pepluanol A. By using a cycloheptenone derivative as a reaction raw material, a key tricyclic skeleton is constructed by means of key steps such as a Negishi coupling reaction, a D...
|
|
WO/2023/146816A1 |
The present disclosure provides novel 4-substituted-phenyl acetamide and arylurea derivatives that act as agonists against GPR88. The compounds of the present disclosure are believed to be useful for the treatment of diseases and conditi...
|
|
WO/2023/146343A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2023/144370A1 |
The current invention relates to an agrochemical composition comprising at least one agrochemical active component and a solvent. Furthermore, the present invention also relates to a method for applying aforementioned agrochemical compos...
|
|
WO/2023/142641A1 |
Provided are a compound of formula I, a stereoisomer or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, a preparation method for the compound and a use thereof in preparation of drugs for...
|
|
WO/2023/146344A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2023/145535A1 |
This resist composition contains a resin component having a structural unit derived from a compound represented by general formula (a0-1) or a structural unit derived from a compound represented by general formula (a0-2). In the formulae...
|
|
WO/2023/144733A1 |
The present invention relates to compounds and a process for the preparation of eribulin. More specifically, the process to prepare the C14- C35 sulfone fragment of eribulin (i.e. compounds of formula I) by reacting a C14-C26 ketone frag...
|
|
WO/2023/144199A1 |
The present invention provides improved crops of the family Asteraceae which have a reduced level of bitter taste secondary metabolites, particularly a reduced level of guaianolide sesquiterpene lactones such as kauniolide. More particul...
|
|
WO/2023/142460A1 |
The present invention discloses a method for synthesizing aryl phenol by means of a reaction between an aryl halide and a phenol compound under the induction of visible light, which method comprises: under the protection of an inert gas,...
|
|
WO/2023/142492A1 |
The present application relates to the field of organic light-emitting materials, and in particular to an organic compound, an electronic component, and an electronic device. The structure of the organic compound is as represented by for...
|
|
WO/2023/138854A1 |
The present invention relates to the synthesis of di(hydroxymethyl)tetrahydrofuran (DHMTHF) and the preparation of trans-enriched mixtures of DHMTHF. The invention further refers to polyester polyols which are obtained by reaction of cis...
|
|
WO/2023/136595A1 |
The present invention is directed to an organic compound employed in an organic layer, such as a hole transport layer, in an organic light emitting device, wherein the organic compound has a lower refractive index than conventional hole ...
|
|
WO/2023/134595A1 |
The present invention relates to a polymerizable compound, a composition, and a liquid crystal display device. The polymerizable compound of the present invention has a structure represented by general formula I described below. The poly...
|
|
WO/2023/136617A1 |
The present invention relates to a method for producing an intermediate useful for the synthesis of an SGLT inhibitor. According to the present invention, a compound of chemical formula 9, which is an important intermediate for a compoun...
|
|
WO/2023/136334A1 |
This method for producing a compound represented by formula (I) involves forming at least one bond between a carbon atom and a nitrogen atom in an aromatic ring of the compound represented by formula (I) through a reaction using a pallad...
|
|
WO/2023/132352A1 |
The present invention provides a method that is for producing an amide compound, that comprises obtaining an amide compound by causing a reaction between a carboxylic acid compound and an amine compound in the presence of a condensing ag...
|
|
WO/2023/132488A1 |
The present specification relates to a compound of chemical formula 1, and an organic light-emitting device comprising same.
|
|
WO/2023/128498A1 |
The present invention relates to a method for producing a furandicarboxylic acid compound, comprising the steps of: producing a hydroxyl furfural compound from a hydroxyl-free furfural compound; and producing a furandicarboxylic acid com...
|
|
WO/2023/125667A1 |
Described herein is the preparation of a compound for treating gout or hyperuricemia and chemical intermediates used in the synthetic process.
|
|
WO/2023/124963A1 |
An antibody-drug conjugate having reduced reversible reaction, and a preparation method therefor and an application thereof. Specifically provided are an antibody-drug conjugate represented by formula (I), a pharmaceutically acceptable s...
|
|
WO/2023/125067A1 |
A CoCu xO y catalyst, the molar ratio of Co, Cu and O thereof being 1:(0.2-1):(3-4). A preparation method of the catalyst comprises: dropwise adding a solution of an oxidizing agent and an initiator into a mixed aqueous solution of coppe...
|
|
WO/2023/127845A1 |
Provided is a compound represented by general formula (1C-A). (In the general formula (1C-A), one of R4 to R8 and R10 to R12 represents a group represented by general formula (1D-A); the others of R4 to R8 and R10 to R12 and R1 to R3 and...
|
|
WO/2023/127844A1 |
Provided is a compound represented by general formula (1A-A). (In general formula (1A-A), one of R4 to R8 and R10 to R12 represents a group represented by any one of general formulae (1B-A1) to (1B-A3); the others of R4 to R8 and R10 to ...
|
|
WO/2023/127843A1 |
An organic electroluminescent element (1B) comprises an anode (3), a cathode (4), and a light-emitting region (5B) disposed between the anode (3) and the cathode (4). The light-emitting region (5B) includes a first light-emitting layer (...
|
|
WO/2023/117406A1 |
The invention relates to a method for producing an aqueous solution of 5-hydroxymethylfurfural (5-HMF), involving the following steps in succession: a) bringing a feed containing 5-HMF and dimethyl sulfoxide (DMSO) into contact with an i...
|
|
WO/2023/120152A1 |
Provided are: a diamantane compound that makes it possible to produce an organic electroluminescence element that achieves excellent light-emission efficiency characteristics or, more preferably, excellent drive voltage characteristics a...
|
|
WO/2023/115220A1 |
A combination comprising tilorone/nelfinavir; tilorone/molnupinavir; tilorone/remdesivir; tilorone/alfacalcidol; tilorone/clofazimine; tilorone/danazol; tilorone/manidipine; tilorone/sertraline; tilorone/trifluoperazine; remdesivir/hexac...
|
|
WO/2023/120250A1 |
Provided is an actinic-ray-sensitive or radiation-sensitive resin composition, etc. that, when forming an ultra-fine pattern (for example, a line and space pattern of 25 nm or less, or a hole pattern with a hole diameter of 25 nm or less...
|
|
WO/2023/119910A1 |
Provided is a radiation-sensitive composition containing: a polymer having an acid dissociable group; and at least one compound (b) selected from the group consisting of a compound represented by formula (1) and a compound represented by...
|
|
WO/2023/120425A1 |
The present invention pertains to a brain function improving agent for preventing the onset of, treating, and/or ameliorating cognitive function impairment and depressive symptoms in central nervous system diseases, the agent being chara...
|
|
WO/2023/122251A2 |
The present disclosure relates to microbial hosts, enzymes, and methods for biosynthesis of lactones.
|
|
WO/2023/117407A1 |
The invention relates to a method for producing an aqueous 5-hydroxymethylfurfural (5-HMF) solution, comprising: - a step a) of bringing a feed containing 5-HMF and dimethyl sulfoxide (DMSO) into contact with an intermediate aqueous back...
|
|
WO/2023/119107A1 |
The present invention relates to a bonding resin useful for example in the manufacture of laminates, mineral wool insulation and wood products such as plywood, oriented strandboard (OSB), laminated veneer lumber (LVL), medium density fib...
|
|
WO/2023/119106A1 |
The present invention relates to a bonding resin useful for example in the manufacture of laminates, mineral wool insulation and wood products such as plywood, oriented strandboard (OSB), laminated veneer lumber (LVL), medium density fib...
|
|
WO/2023/118434A1 |
The present invention relates to novel pesticidally active amide compounds and in particular heteroaromatic amide compounds, to compositions comprising those compounds, and to their use in agriculture, for example in controlling insect p...
|
|
WO/2023/115394A1 |
A diarylamine compound and use thereof, a light extraction material, an electroluminescent device, and a display device. The structural general formula of the diarylamine compound is formula (I).
|
|
WO/2023/120452A1 |
This SREBP-1 inhibitor has inhibitory activity against SREBP-1 and does not have inhibitory activity against SREBP-2, the SREBP-1 inhibitor containing, as an active ingredient, one or more compounds from among compounds represented by fo...
|
|
WO/2023/120485A1 |
An organic EL element (1) has a light-emitting region (5) and a first positive electrode-side organic layer (61). The first positive electrode-side organic layer (61) contains a first material. The light-emitting region (5) includes a fi...
|
|
WO/2023/122724A1 |
The present disclosure pertains to a new synthetic method for the preparation of 3,6-dimethylhexahydrobenzofuran-2-one, a derivative of mint lactone, and an important organoleptic compound which finds use in the flavor and fragrance indu...
|
|
WO/2023/115843A1 |
Disclosed in the present invention is a method for producing 1,4-butanediol and co-producing succinic anhydride by means of direct hydrogenation of maleic anhydride. Maleic anhydride and hydrogen are used as raw materials to obtain 1,4-b...
|
|
WO/2023/115203A1 |
Disclosed are compounds of formula (I), wherein ring A is an 8-10 membered aromatic or partially aromatic bicyclic ring having 1-4 heteroatoms compositions thereof, wherein L1, L2, R1 to R4 and m are as defined in claim 1; and methods of...
|
|
WO/2023/120638A1 |
A main chain polymer according to one embodiment of the present invention has, in the polymer main chain, a photoreactive reverse wavelength dispersion unit which has both photoreactivity and reverse wavelength dispersion of birefringenc...
|
|
WO/2023/112033A2 |
The present invention relates to various compounds, which are novel and useful intermediates in novel methods for preparation of certain compounds referred to as Saturated Targets and amorphous and crystal forms thereof, and certain mark...
|
|
WO/2023/113456A1 |
The present invention relates to a compound capable of degrading a target protein by using ubiquitination, and provides a compound having a targeted protein binding moiety (TBM) structure, which binds to a target protein or polypeptide, ...
|
|
WO/2023/113457A1 |
The present invention relates to a compound capable of degrading a target protein by using ubiquitination, and provides a compound having a targeted protein binding moiety (TBM) structure, which binds to a target protein or polypeptide, ...
|
|
WO/2023/114459A2 |
The invention provides neo acids (NAs) and derivatives thereof. Also provided is a method for producing a NA, comprising hydrodeoxygenation (HDO) of a furan- containing neo acid (FNA) in the presence a metal triflate and a hydrogenation ...
|
|
WO/2023/115002A1 |
The present disclosure relates to compound Formula (I) methods for making the compounds and methods for their use.
|
